Trial Profile
ANTITHROMBOTIC THERAPY IN THE DIABETIC PATIENT: STUDY ON THE EFFECT ON PLATELET FUNCTIONALITY OF A GREATER DOSAGE OF ASPIRIN OR THE ASSOCIATION OF LOW DOSES OF ASPIRIN PLUS SELECTIVE INHIBITOR OF THE COX-2
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2014
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Etoricoxib (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 10 Jul 2014 New trial record